CVS.DECVS.DEXETRA
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.9%
5Y CAGR+7.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+9.9%/yr
vs +15.6%/yr prior
5Y CAGR
+7.6%/yr
Consistent
Acceleration
-5.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $50.70B | +18.2% |
| 2024 | $42.88B | +5.4% |
| 2023 | $40.69B | +6.5% |
| 2022 | $38.21B | +3.1% |
| 2021 | $37.07B | +5.5% |
| 2020 | $35.13B | +4.8% |
| 2019 | $33.54B | +57.0% |
| 2018 | $21.37B | +12.3% |
| 2017 | $19.03B | +2.7% |
| 2016 | $18.52B | - |